Molina Healthcare Added to Wedbush's Best Ideas List
Wedbush analyst Sarah James added Outperform rated Molina Healthcare (NYSE: MOH) to the Best Ideas List.
James reported that the investors are waiting for a selloff to buy Molina Healthcare may not succeed as California EBIT margin guarantee makes the stock drop less likely. The analyst noted that the next catalyst may be in late January on investor day where Molina could raise its 2015 revenue forecast above consensus.
Shares of Molina Healthcare rose 28% in 2013 versus the S6HLTH which was up 56%. Molina closed at $34.75 on Tuesday and shares have traded as high as $36.58, up approximately 5.266%.
Latest Ratings for MOH
|Jan 2017||PiperJaffray||Initiates Coverage On||Overweight|
|Dec 2016||Goldman Sachs||Upgrades||Neutral||Buy|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.